— Lam Research Corp. (NASDAQ: LRCX) reported its second-quarter 2020 adjusted earnings of $4.01 per share versus $3.85 per share expected.
— Revenue rose by 2% to $2.58 billion versus $2.51 billion expected.
— Deferred revenue at the end of December 2019 quarter fell to $411 million from $481 million in the previous quarter. The balance does not include shipments to customers in Japan, to whom the title does not transfer until customer acceptance.
— Looking ahead into the third quarter, the company expects revenue in the range of $2.6-3.0 billion. The consensus estimates revenue of $2.58 billion.
— The earnings are anticipated to be in the range of $4.06-4.86 per share and adjusted earnings are predicted to be $4.15-4.95 per share. The market analysts predict EPS of $4.00.
— Gross margin is projected to be in the range of 45.4% to 47.4% and the operating margin is predicted to be 26.5% to 28.5% for the third quarter.
— Cash and cash equivalents, short-term investments, and restricted cash and investments balances fell by 16% at the end of the December 2019 quarter from the previous quarter. This was due to share repurchases, dividends paid and capital expenditures.
Trxade Health Inc. (NASDAQ: MEDS) is an online pharmaceutical marketplace that provides a platform for independent pharmacies to operate more effectively. The company’s digital platform helps optimize drug procurement and
It is estimated that the size of the global chip manufacturing equipment market would nearly double from the current levels to about $142 billion in the next eight years. Applied
Shares of Take-Two Interactive Software (NASDAQ: TTWO) were down over 2% on Friday. The stock has dropped 32% year-to-date and 35% over the past 12 months. Earlier this week, the